Regulation of IL-17 Expression by the Developmental Pathway of CD4 T Cells in the Thymus

Overview

Journal Mol Immunol

Specialties Allergy & Immunology
Molecular Biology

Date 2010 Jan 19

PMID 20080304

Citations 4

Authors

M Hanief Sofi

Zhiping Liu

Lingqiao Zhu

Qiao Yu

Mark H Kaplan

Cheong-Hee Chang

Affiliations

Soon will be listed here.

Abstract

CD4 T cells selected by MHC class II expressing thymocytes (T-CD4 T cells) have distinct effector functions compared to that of epithelial cell-selected CD4 T cells (E-CD4 T cells). T-CD4 T cells produce both Th1 and Th2 effector cytokines immediately after stimulation and also express IL-4 in addition to IFN-gamma under the Th1 differentiation condition. In the present study, we investigated the capability of T-CD4 T cells to become IL-17-producing cells. We found that T-CD4 T cells express reduced IL-17 under Th17-inducing conditions. T-CD4 T cells express very low levels of receptor for TGF-beta and IL-21 that are essential to induce IL-17 expression. In addition, the induction of RORgammat, a key transcription factor for IL-17 gene expression, was compromised in T-CD4 T cells under Th17 skewing conditions and ectopic expression of RORgammat restored IL-17 expression. The defect of IL-17 and RORgammat expression in T-CD4 T cells is cell intrinsic and not due to effects of a secreted factor. Thus, the developmental pathway of CD4 T cells in the thymus plays a critical role in controlling an immune response by suppressing the generation of the Th17 lineage.

Citing Articles

The circadian gene Arntl2 on distal mouse chromosome 6 controls thymocyte apoptosis.

Lebailly B, Langa F, Boitard C, Avner P, Christine Rogner U Mamm Genome. 2016; 28(1-2):1-12.

PMID: 27671790 DOI: 10.1007/s00335-016-9665-4.

Milk fat globule-epidermal growth factor-factor VIII downregulates interleukin-17 expression in sepsis by modulating STAT3 activation.

Cen C, Aziz M, Yang W, Nicastro J, Coppa G, Wang P Surgery. 2015; 159(2):560-9.

PMID: 26376757 PMC: 4707120. DOI: 10.1016/j.surg.2015.08.011.

Innate-like CD4 T cells selected by thymocytes suppress adaptive immune responses against bacterial infections.

Qiao Y, Gray B, Sofi M, Bauler L, Eaton K, ORiordan M Open J Immunol. 2012; 2(1):25-39.

PMID: 23264931 PMC: 3525959. DOI: 10.4236/oji.2012.21004.

Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection.

Dubin P, Martz A, Eisenstatt J, Fox M, Logar A, Kolls J Infect Immun. 2011; 80(1):398-409.

PMID: 22025517 PMC: 3255685. DOI: 10.1128/IAI.05821-11.

References

Mars L, Araujo L, Kerschen P, Diem S, Bourgeois E, Pham Van L . Invariant NKT cells inhibit development of the Th17 lineage. Proc Natl Acad Sci U S A. 2009; 106(15):6238-43. PMC: 2669382. DOI: 10.1073/pnas.0809317106. View

Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y . A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005; 6(11):1133-41. PMC: 1618871. DOI: 10.1038/ni1261. View

Wang N, Satoskar A, Faubion W, Howie D, Okamoto S, Feske S . The cell surface receptor SLAM controls T cell and macrophage functions. J Exp Med. 2004; 199(9):1255-64. PMC: 2211908. DOI: 10.1084/jem.20031835. View

Huber M, Brustle A, Reinhard K, Guralnik A, Walter G, Mahiny A . IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A. 2008; 105(52):20846-51. PMC: 2634912. DOI: 10.1073/pnas.0809077106. View

McGeachy M, Bak-Jensen K, Chen Y, Tato C, Blumenschein W, Mcclanahan T . TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007; 8(12):1390-7. DOI: 10.1038/ni1539. View

Lio C, Hsieh C . A two-step process for thymic regulatory T cell development. Immunity. 2008; 28(1):100-11. PMC: 2248212. DOI: 10.1016/j.immuni.2007.11.021. View

Mangan P, Harrington L, OQuinn D, Helms W, Bullard D, Elson C . Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006; 441(7090):231-4. DOI: 10.1038/nature04754. View

Li W, Sofi M, Yeh N, Sehra S, McCarthy B, Patel D . Thymic selection pathway regulates the effector function of CD4 T cells. J Exp Med. 2007; 204(9):2145-57. PMC: 2118694. DOI: 10.1084/jem.20070321. View

Li W, Sofi M, Rietdijk S, Wang N, Terhorst C, Chang C . The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction. Immunity. 2007; 27(5):763-74. PMC: 2757291. DOI: 10.1016/j.immuni.2007.10.008. View

10.

Avni O, Lee D, Macian F, Szabo S, Glimcher L, Rao A . T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol. 2002; 3(7):643-51. DOI: 10.1038/ni808. View

11.

Murphy K, Ouyang W, Farrar J, Yang J, Ranganath S, Asnagli H . Signaling and transcription in T helper development. Annu Rev Immunol. 2000; 18:451-94. DOI: 10.1146/annurev.immunol.18.1.451. View

12.

Park W, Bae Y, Chung D, Choi Y, Kim B, Sung Y . T cell expression of CIITA represses Th1 immunity. Int Immunol. 2004; 16(10):1355-64. DOI: 10.1093/intimm/dxh132. View

13.

Bauquet A, Jin H, Paterson A, Mitsdoerffer M, Ho I, Sharpe A . The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol. 2008; 10(2):167-75. PMC: 2742982. DOI: 10.1038/ni.1690. View

14.

Sisk T, Gourley T, Roys S, Chang C . MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J Immunol. 2000; 165(5):2511-7. DOI: 10.4049/jimmunol.165.5.2511. View

15.

Chang C, Flavell R . Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med. 1995; 181(2):765-7. PMC: 2191893. DOI: 10.1084/jem.181.2.765. View

16.

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

17.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

18.

Gourley T, Roys S, Lukacs N, Kunkel S, Flavell R, Chang C . A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity. 1999; 10(3):377-86. DOI: 10.1016/s1074-7613(00)80037-0. View

19.

Shiomi S, Toriie A, Imamura S, Konishi H, Mitsufuji S, Iwakura Y . IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter. 2009; 13(6):518-24. PMC: 2631559. DOI: 10.1111/j.1523-5378.2008.00629.x. View

20.

van Hamburg J, de Bruijn M, Ribeiro de Almeida C, van Zwam M, van Meurs M, de Haas E . Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology. Eur J Immunol. 2008; 38(9):2573-86. DOI: 10.1002/eji.200737840. View